The review of selected biomarkers of abdominal aortic aneurysm

Abdominal aortic aneurysm (AAA) is a disease affecting the main artery transporting oxidized blood to theabdominal and pelvic organs. Abdominal aortic aneurysms occur 4-8 times more often in men than in women,usually develop after the age of 55. Among men over 65, 4–7.6%, this diagnosis can be expected. More aneurysmsoccur in Caucasian people. Among the most frequently mentioned in the literature, AAA risk factors areolder age, male gender, positive family history, smoking, chronic obstructive pulmonary disease, hypertension,hypercholesterolemia, peripheral arterial occlusive disease, ischemic heart disease. Biochemical tests to determinethe level of AAA-specific markers appear with potential. There are reports in the literature on the possibleuse of concentrations of selected molecules in the diagnosis of AAA. According to cadaveric research, there arenoticed dimensions of the abdominal aorta at its different levels. The relation between aortic size and shapecan be the factor contributing to the development of AAA. Previous studies have shown that the developmentof AAA is a crucial fundamental inflammatory response in conjunction with proteolysis tissue, which causes thedestruction and reconstruction of the blood vessel wall. Numerous factors contribute to the pathogenesis ofAAA: proteins, transcription factors, enzymes and microRNAs. The increase in the concentration of most factorsis associated with inflammation. The biomarkers presented in the paper are not limited to AAA, and thus canbe used only for visual assessment of the degree of abdominal aortic aneurysm development